Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Histone Deacetylase Inhibitors: Potent Inducers of Tumor Latent EBV Thymidine Kinase Induction

Douglas V Faller, Sajal K Ghosh, Susan P Perrine, MD, Robert M Williams, Ronald J Berenson, MD

Blood (2010) 116 (21): 1831.

https://doi.org/10.1182/blood.V116.21.1831.1831

Published: 2010

Journal Articles

Anti-Myeloma Activity of Enzymatically Activated Melphalan Prodrug J1

Dharminder Chauhan, PhD, Madhavi Bandi, Ajita V Singh, Klaus Podar, Paul G Richardson, Nikhil C. Munshi, Kristina Viktorsson, Rolf Lewensohn, Jack Spira, Kenneth C. Anderson

Blood (2010) 116 (21): 1838.

https://doi.org/10.1182/blood.V116.21.1838.1838

Published: 2010

Journal Articles

Dysregulation of Metabolic Genes May Be Normalized by Epigenetic Drugs (Vorinostat, Decitabine) and Nutritional Compounds (Genistein, Vitamin D) in Leukemic Cells.

Heidrun Karlic, PhD, Franz Varga, PhD, Elisabeth Pittermann, MD, Michael Pfeilstocker, MD

Blood (2009) 114 (22): 4423.

https://doi.org/10.1182/blood.V114.22.4423.4423

Published: 2009

Journal Articles

Potent Inhibition of EEC Colony Formation in JAK2 V617F PV and ET by Low Doses of ITF2357, a New Histone Deacetylase Inhibitor.

Vittoria Guerini, PhD, Orietta Spinelli, Biol Sc, Anna Salvi, Guido Finazzi, MD, Tiziano Barbui, MD, Martino Introna, MD, Josee Golay, Biol Sc, Alessandro Rambaldi, MD

Blood (2006) 108 (11): 2702.

https://doi.org/10.1182/blood.V108.11.2702.2702

Published: 2006

Journal Articles

Identification of Candidate Tumor Suppressor Genes Silenced Epigenetically in Mantle Cell Lymphoma.

Norihiko Kawamata, MD, Takayuki Saitoh, MD, Sakura Sakajiri, MD, Phillip H. Koeffler, MD

Blood (2005) 106 (11): 3001.

https://doi.org/10.1182/blood.V106.11.3001.3001

Published: 2005

Journal Articles

Final Results of a Phase I Study of the Histone Deacetylase Inhibitor Vorinostat (Suberoyanilide Hydroxamic Acid, SAHA), in Patients with Leukemia and Myelodysplastic Syndrome.

Guillermo Garcia-Manero, MD, Hui Yang, MD, PhD, Blanca Sanchez-Gonzalez, MD, Srdan Verstovsek, MD, Alessandra Ferrajoli, MD, Michael Keating, MD, Michael Andreeff, MD, Susan O’Brien, MD, Jorge Cortes, MD, William Wierda, MD, PhD, Stefan Faderl, MD, Charles Koller, MD, Jan Davis, RN, Gail Morris, RN, Jean-Pierre Issa, MD, Stanley R. Frankel, MD, Victoria Richon, PhD, Bernard Fine, PhD, Hagop Kantarjian, MD

Blood (2005) 106 (11): 2801.

https://doi.org/10.1182/blood.V106.11.2801.2801

Published: 2005

Journal Articles

Identification of Epigenetically Silenced Tumor Suppressor Genes in Myeloid Disorders Leads to the Identification of α-Catenin as a Target Gene in 5q- Syndrome.

J. C. Desmond, S. D. Raynaud, L. C. Jones, W. K. Hofmann, T. Haferlach, H. Phillip Koeffler

Blood (2004) 104 (11): 2565.

https://doi.org/10.1182/blood.V104.11.2565.2565

Published: 2004

NARROW

Histone Deacetylase Inhibitors: Potent Inducers of Tumor Latent EBV Thymidine Kinase Induction

Anti-Myeloma Activity of Enzymatically Activated Melphalan Prodrug J1

Dysregulation of Metabolic Genes May Be Normalized by Epigenetic Drugs (Vorinostat, Decitabine) and Nutritional Compounds (Genistein, Vitamin D) in Leukemic Cells.

Potent Inhibition of EEC Colony Formation in JAK2 V617F PV and ET by Low Doses of ITF2357, a New Histone Deacetylase Inhibitor.

Identification of Candidate Tumor Suppressor Genes Silenced Epigenetically in Mantle Cell Lymphoma.

Final Results of a Phase I Study of the Histone Deacetylase Inhibitor Vorinostat (Suberoyanilide Hydroxamic Acid, SAHA), in Patients with Leukemia and Myelodysplastic Syndrome.

Identification of Epigenetically Silenced Tumor Suppressor Genes in Myeloid Disorders Leads to the Identification of α-Catenin as a Target Gene in 5q- Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Histone Deacetylase Inhibitors: Potent Inducers of Tumor Latent EBV Thymidine Kinase Induction

Anti-Myeloma Activity of Enzymatically Activated Melphalan Prodrug J1

Dysregulation of Metabolic Genes May Be Normalized by Epigenetic Drugs (Vorinostat, Decitabine) and Nutritional Compounds (Genistein, Vitamin D) in Leukemic Cells.

Potent Inhibition of EEC Colony Formation in JAK2 V617F PV and ET by Low Doses of ITF2357, a New Histone Deacetylase Inhibitor.

Identification of Candidate Tumor Suppressor Genes Silenced Epigenetically in Mantle Cell Lymphoma.

Final Results of a Phase I Study of the Histone Deacetylase Inhibitor Vorinostat (Suberoyanilide Hydroxamic Acid, SAHA), in Patients with Leukemia and Myelodysplastic Syndrome.

Identification of Epigenetically Silenced Tumor Suppressor Genes in Myeloid Disorders Leads to the Identification of α-Catenin as a Target Gene in 5q- Syndrome.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only